E.L. Levine

1.7k total citations · 1 hit paper
17 papers, 1.4k citations indexed

About

E.L. Levine is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, E.L. Levine has authored 17 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in E.L. Levine's work include DNA Repair Mechanisms (3 papers), Colorectal Cancer Surgical Treatments (3 papers) and Colorectal and Anal Carcinomas (3 papers). E.L. Levine is often cited by papers focused on DNA Repair Mechanisms (3 papers), Colorectal Cancer Surgical Treatments (3 papers) and Colorectal and Anal Carcinomas (3 papers). E.L. Levine collaborates with scholars based in United Kingdom, United States and Austria. E.L. Levine's co-authors include Daniel Hwang, David J. Scott, SA Roberts, W. Burrill, Catharine West, G G Ribeiro, Jean A. Maroun, J McKendrick, Howard A. Burris and S.E. Davidson and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and British Journal of Cancer.

In The Last Decade

E.L. Levine

17 papers receiving 1.3k citations

Hit Papers

Expression of Cyclooxygenase-1 and Cyclooxygenase-2 in Hu... 1998 2026 2007 2016 1998 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Expression of Cyclooxygenase-1 and Cyclooxygenase-2 in Human Breast Cancer
    1998 558 citations Daniel Hwang, E.L. Levine et al. JNCI Journal of the National Cancer Institute profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E.L. Levine United Kingdom 11 481 445 386 351 290 17 1.4k
Sven Petersen Singapore 14 454 0.9× 335 0.8× 238 0.6× 330 0.9× 167 0.6× 21 1.3k
Hiroyuki Achiwa Japan 15 659 1.4× 753 1.7× 449 1.2× 605 1.7× 329 1.1× 28 1.7k
Mingxin Che United States 25 582 1.2× 215 0.5× 239 0.6× 703 2.0× 440 1.5× 36 1.9k
B L Kemp United States 13 505 1.0× 231 0.5× 325 0.8× 690 2.0× 324 1.1× 20 1.4k
Mangesh A. Thorat United Kingdom 19 690 1.4× 189 0.4× 304 0.8× 701 2.0× 559 1.9× 54 1.7k
Chelsea Robinson United States 5 622 1.3× 914 2.1× 491 1.3× 341 1.0× 337 1.2× 9 1.7k
Kishore Guda United States 21 421 0.9× 167 0.4× 221 0.6× 880 2.5× 432 1.5× 47 1.6k
Kiyoshi Koshida Japan 19 218 0.5× 98 0.2× 185 0.5× 502 1.4× 183 0.6× 80 1.2k
Denise K. Oelschlager United States 20 325 0.7× 92 0.2× 155 0.4× 602 1.7× 197 0.7× 41 1.2k
Joseph M. Giaconia United States 11 262 0.5× 137 0.3× 206 0.5× 801 2.3× 242 0.8× 14 1.6k

Countries citing papers authored by E.L. Levine

Since Specialization
Citations

This map shows the geographic impact of E.L. Levine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.L. Levine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.L. Levine more than expected).

Fields of papers citing papers by E.L. Levine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.L. Levine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.L. Levine. The network helps show where E.L. Levine may publish in the future.

Co-authorship network of co-authors of E.L. Levine

This figure shows the co-authorship network connecting the top 25 collaborators of E.L. Levine. A scholar is included among the top collaborators of E.L. Levine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.L. Levine. E.L. Levine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Gollins, Simon, Swe Swe Myint, S. Susnerwala, et al.. (2010). Preoperative chemoradiation (CRT) with concurrent capecitabine and irinotecan in MRI-defined locally advanced rectal cancer: Relationship of histologic downstaging to long-term survival end points.. Journal of Clinical Oncology. 28(15_suppl). 3636–3636. 3 indexed citations
3.
Badie, Christophe, Theodora Tsigani, Ghazi Alsbeih, et al.. (2008). Aberrant CDKN1A transcriptional response associates with abnormal sensitivity to radiation treatment. British Journal of Cancer. 98(11). 1845–1851. 62 indexed citations
4.
Myint, Arthur Sun, Robert Grieve, Alec McDonald, et al.. (2007). Combined Modality Treatment of Early Rectal Cancer — the UK Experience. Clinical Oncology. 19(9). 674–681. 34 indexed citations
5.
Molassiotis, Alex, Mark Saunders, Juan W. Valle, et al.. (2007). A prospective observational study of chemotherapy-related nausea and vomiting in routine practice in a UK cancer centre. Supportive Care in Cancer. 16(2). 201–208. 91 indexed citations
6.
Levine, E.L., Simon Gollins, S. Susnerwala, et al.. (2004). Phase II study of radiotherapy plus concurrent irinotecan (CPT-11) and infusional 5-fluorouracil (5FU) in the treatment of T3-T4 locally advanced inoperable rectal cancer. Journal of Clinical Oncology. 22(14_suppl). 3612–3612. 7 indexed citations
7.
Scheithauer, Werner, J McKendrick, S. Begbie, et al.. (2003). Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial. Annals of Oncology. 14(12). 1735–1743. 222 indexed citations
8.
Roberts, S. A., E.L. Levine, & David Scott. (2003). Influence of intrinsic radiosensitivity on the survival of breast cancer patients. International Journal of Radiation Biology. 79(5). 311–317. 3 indexed citations
9.
Fakhoury, Hana, E.L. Levine, J. Wylie, et al.. (2003). Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients. International Journal of Radiation Biology. 79(2). 137–143. 51 indexed citations
10.
Allan, E., David Pye, E.L. Levine, & James V. Moore. (2002). Non-Invasive Pulsed Ultrasound Quantification of the Resolution of Basal Cell Carcinomas After Photodynamic Therapy. Lasers in Medical Science. 17(4). 230–237. 17 indexed citations
11.
Hwang, Daniel, et al.. (1998). Expression of Cyclooxygenase-1 and Cyclooxygenase-2 in Human Breast Cancer. JNCI Journal of the National Cancer Institute. 90(6). 455–460. 558 indexed citations breakdown →
12.
13.
Levine, E.L., Andrew G. Renehan, S.E. Davidson, et al.. (1995). Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma. Radiotherapy and Oncology. 37(1). 1–9. 134 indexed citations
14.
Levine, E.L., P.A. Burt, R. Stout, & Bridget Kane. (1995). The efficacy of megavoltage imaging in the radical radiotherapy of non-small cell lung cancer. British Journal of Radiology. 68(810). 646–648. 1 indexed citations
15.
Levine, E.L. & G G Ribeiro. (1994). Vitiligo and radiotherapy: The koebner phenomenon demonstrated in patients with vitiligo undergoing radiotherapy for carcinoma of the breast. Clinical Oncology. 6(2). 133–134. 26 indexed citations
16.
Levine, E.L.. (1992). Transitional cell carcinoma of the renal pelvis associated with cyclophosphamide therapy.. American Journal of Roentgenology. 159(5). 1027–1028. 10 indexed citations
17.
Lehrer, Steven, et al.. (1988). Breast size, endogenous estrogens, and breast cancer: a review with hypothesis.. PubMed. 55(2). 142–3. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sven Petersen Breakdown of academic impact, for papers by Hiroyuki Achiwa Breakdown of academic impact, for papers by Mingxin Che Breakdown of academic impact, for papers by B L Kemp Breakdown of academic impact, for papers by Mangesh A. Thorat Breakdown of academic impact, for papers by Chelsea Robinson Breakdown of academic impact, for papers by Kishore Guda Breakdown of academic impact, for papers by Kiyoshi Koshida Breakdown of academic impact, for papers by Denise K. Oelschlager Breakdown of academic impact, for papers by Joseph M. Giaconia
Rankless by CCL
2026